drugset / Trial / NCT01730846

Does Doxazosin Attenuate Stress-induced Smoking and Improve Clinical Outcomes?

NCT01730846

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to examine whether doxazosin will attenuate the ability of stress to precipitate smoking lapse behavior in treatment seeking daily smokers. Participants will participate in a smoking cessation attempt after the laboratory sessions.

Timeline

Start
2013-02
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxazosin Small molecule 4 mg
Subject Doxazosin Small molecule 8 mg

Indications

No indication recorded.